One-stop shop for European life sciences companies

Track record
Products and services
Transactions
Contact

Life sciences & healthcare

Established as the premier, pan-European, specialist investment bank in the life sciences & healthcare sector, Van Lanschot Kempen is a trusted adviser with many repeat clients. We are your one-stop shop with top-tier international expertise and a global investor network. Our Life Sciences & Healthcare team combines in-depth sector knowledge, scientific background and business experience. For corporate clients, our goal is to ensure that all M&A and ECM transaction processes run smoothly, while achieving the best results. For investors, we offer high-quality analysis of the broadest small/mid-cap European life sciences coverage, as well as trade execution and liquidity through our specialised marketing and trading services.

Unrivalled track record

Consistently successful results for our clients have led to high levels of repeat business, helping Van Lanschot Kempen build outstanding credentials over the years.

Leading pan-European bank for ECM transactions in the life sciences & healthcare sector
Outstanding stock-picking track record, consistently beating healthcare indices
Connecting EU life sciences companies with global institutional investors
Experts in block trades and providing liquidity
More than 175 successfully executed transactions, raising over €10 billion
Access to both European and US capital markets

Products and services

Benefit from our specialist sector knowledge with solutions tailored exclusively to life sciences & healthcare.

Mergers & acquisitions

For both listed and private companies, with extensive experience in sell-side and buy-side.

Corporate advisory

Buy- and sell-side advisory for cross-border deals, strategic financial advice on capital structuring, and ECM services such as IPOs and public-to-private transactions.

Equities trading

Specialists in large (block) trades, orderly venture capital exits and liquidity provision.

Debt advisory

Independent advice on debt financing and achievement of optimal capital structures.

Equities research

Coverage of approx. 60 listed small/mid-cap companies, providing in-depth analyses based on our in-house sector expertise.

Equities sales

Bringing together global investors and European life sciences companies through roadshows, conferences and other access events.

Equity Capital Markets

Advice on IPOs and other equity capital markets transactions, such as follow-on capital increases, secondary offerings, share buybacks and equity-linked transactions.

Transactions

Great cooperation makes for excellent transactions. Our outstanding sector knowledge combined with a strong focus on understanding stocks and companies ensures we have a superior industry network and distribution power, leading to a successful track record in the market.

November 2023